Products for Research Use Only

T20-M

CAT: 0804-HY-P10800Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10800Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
T20-M is a lead peptide that shows good potential for binding affinity towards UBE2C[1].
UNSPSC
12352209
Target
Deubiquitinase
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
O=C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](CCSC)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N
Molecular Formula
C87H140N22O26S
Molecular Weight
1942.24
References & Citations
[1]Añonuevo AM, et al. In silico de novo drug design of a therapeutic peptide inhibitor against UBE2C in breast cancer. J Bioinform Comput Biol. 2023 Feb;21 (1) :2250029.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported